Facebook Youtube Yelp Instagram
Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks
Home > Blog > Tags > HPV
Subscribe to this list via RSS Blog posts tagged in HPV
150721NewHPVRecsWhen a new and improved Human Papillomavirus vaccine, called Gardasil 9, became available earlier this year to better prevent cervical cancer, doctors and parents quickly asked: What about kids who have already finished their Gardasil 4 series?

As the name indicates, Gardasil 9 covers nine strains of the potentially deadly virus, compared to the four-strain vaccine many children have received.

Human Papilloma Virus is the cause of cervical cancer, penile cancer and genital warts, affecting both young women and men. This virus: spreads quickly by skin-to-skin contact, is extremely contagious, and is known to infect millions of young adults in the U.S.

Ten thousand new cases of cervical cancer are diagnosed each year; 4,000 deaths annually make cervical cancer the No. 1 cancer killer of 20- 30-year-old women in this country.  

HPV vaccination has proven to be safe and highly effective over many years of use and is already showing impressive declines in the number of new cervical cancer cases in immunized women. The vaccine is strongly recommended for girls 9- to 26-years-old, and boys 9- to 21-years. The shot is given as a series of three injections over 6 months, and is intended to be given before children are old enough to be exposed to the virus.

We have waited eagerly for information on what to recommend to those who’ve finished some or all of their HPV series with the earlier 4-valent version. The Advisory Committee on Immunization Practices for the CDC recommends:  

•    Girls who have already finished their entire series of the Gardasil 4 vaccine may benefit from a single dose of Gardasil 9 to help protect them from the other serious strains of HPV.

•    Boys who have already finished their entire Gardasil 4 series do not need to be boosted with the 9-valent shot because of the lower burden of disease on their gender. Penile cancer is much less common in men than cervical cancer is in women.  

•    Girls and boys who are partially immunized with the Gardasil 4 vaccine (they’ve had one or two doses but need to finish the series) should receive the broader Gardasil 9 vaccine for all subsequent doses.

Eugene Pediatrics is one of the first pediatric clinics in our region to switch entirely to this improved, highly effective vaccine.  

I cannot stress enough how important it is to immunize your tweens and teens against this virus. By doing so, we can defeat one of the top cancer killers in this country.

Posted by on in News

130807HPV-1Human papillomavirus (HPV) vaccination rates have flattened, despite new evidence that the vaccine is both safe and highly effective. While vaccinations of more than one (of three possible) doses of HPV vaccine increased from 25 percent in 2007 to 53 percent in 2011, no measurable increase in vaccinations was observed in females between 2011 and 2012, according to the Centers for Disease Control and Prevention.

While HPV vaccination rates leveled off, other shots recommended for teens steadily increased during the same years (for instance, DTap — combined tetanus, diphtheria and pertussis — and meningococcal vaccines). Most common reasons cited for not vaccinating a child against HPV were:

• Lack of awareness about the shot.
• Doubts of its safety.
• Irrelevance because the adolescent was believed to be having no intimate contact.

Extensive data over many years show that nearly all sexually active men and women will catch at least one strain of HPV infection (contracted through any type of intimate skin-to-skin contact) at some point in their lives. Every year in the United States, 14 million people (mostly young adults) become infected with HPV, leading to 26,000 HPV-related cancers. More than 8,000 of these cancers affect men, so the vaccine is now recommended for both men (under 21) and women (under 26). Every year, of the 17,000 HPV-related cancers in women, more than 4,000 women in our country die of cervical cancer.

In the United States, vaccine safety monitoring and evaluation are very thorough. From June 2006 to March 2013, approximately 56 million doses of HPV4 vaccine were distributed in the United States. For that same period, the total number of reports to CDC and the FDA of adverse events, or undesirable medical experiences, from women following receipt of HPV4 peaked in 2008 and decreased each year thereafter; the proportion of serious reports also decreased.